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tA Systematic Review of Stenting and Angioplasty of Symptomatic
Extracranial Vertebral Artery Stenosis
Staymann AN, Nogueira RG, Gupta R. Stroke 2011;42:2212-6.
Conclusion: Angioplasty and stenting of the extracranial vertebral
arteries has a low rate of periprocedural stroke or transient ischemic attack.
Restenosis rates may not be as high as previously suspected.
Summary: It is increasingly recognized that vertebral artery stenosis
may be a significant etiology for stroke. Stroke registries suggest strokes in
the posterior circulation account for up to 25% of ischemic cerebral vascular
events (Moulin T, Cerebrovasc Dis 2000;10:261-71). Placement of stents at
the origin of the vertebral artery is potentially useful in patients with
vertebral artery stenosis, should it be safe, and reasonably durable. The
authors examined the available data on vertebral artery stenting through a
systematic review of the available literature. The articles and the references
were reviewed to determine the risk and durability of endovascular treat-
ment. The authors identified 27 articles that met inclusion criteria, with 980
of 993 patients treated with stents; of these patients, 56% were noted to have
contralateral vertebral artery stenosis or occlusion, and 92% were described
as “symptomatic” at the time of treatment. Technical success rates were
99.3% as evidenced by 20% residual stenosis at the conclusion of the
procedure. There was a 1.1% incidence of stroke associated with vertebral
artery stenting (n 11 patients) and a 0.8% (n 8) rate of transient ischemic
attack 30 days of the procedure. Bare-metal stents were associated with a
30% restenosis rate, and drug-eluting stents with 11% restenosis rate at a
mean of 24 months.
Comment: The articles selected for review clearly varied in clinical and
angiographic follow-up, outcome measures, and patient selection, limiting
the implications of the data. Nevertheless, the data available suggest the
feasibility and safety of stenting the vertebral artery origin is perhaps better
than generally appreciated. The study did not review medical management
before or after vertebral artery stenting. Clearly, the question remains how
the combination of optimal medical management and vertebral artery stent-
ing will compare with optimal medical management alone in a long-term
prevention of posterior circulation infarct.
Carotid stenosis as predictor of stroke after transient ischemic attacks
Bonifati DM, Lorenzi A, Ermani M, et al. J Neurol Sci 2011;303:85-9.
Conclusion: Patients with elevated ABCD2 scores are at higher risk of
stroke after a recent transient ischemic attack (TIA). A carotid stenosis70%
is an independent risk factor for stroke at any time point.
Summary: Between 4% and 20% of patients will have a stroke90 days
of a first TIA. Half of the strokes occur2 days of the TIA (Johnston SC, et
al, JAMA 2000;284:2901-6). To additionally stratify the risk of stroke after
TIA, risk scoring systems have been developed. A unified risk score involving
the California and ABCD scores was recently developed and termed ABCD2
score. The scoring system is based on five factors: age, blood pressure,
clinical features, duration, and diabetes. Patients with scores4 have a 2-day
stroke risk of 8.1%. Lower scores indicate a 2-day stroke risk of 1%. Data
from the North American Symptomatic Carotid Endarterectomy Trial also
showed a risk of stroke as high as 25% at 90 days in patients with a
hemispheric TIA associated with a 70% carotid stenosis (Streifler JY, et al,
Arch Neurol 1995;52:246-9). In this study, the authors sought to confirm
the usefulness of the ABCD2 score in a cohort of TIA patients and to explore
if computed tomography (CT) scanning or carotid ultrasound imaging may
also be useful in stratifying risk of stroke after TIA.
This was a retrospective review focusing on the emergency department
discharge diagnosis of approximately 120,000 patients seen in one Italian
hospital during a 28-month period. ABCD2 score, carotid ultrasound
images, andCT scans were recorded and correlated with recurrence of stroke
at different intervals (mean follow-up, 11.4 months) in patients with TIA.
The authors were able to identify 965 patients with a focal neurologic deficit,
with 502 classified as TIA. An ischemic stroke recurred in 30 patients at the
end of follow-up, and 30% of these strokes occurred in the first 2 days. An
ABCD2 score dichotomized for 4 and 4 was predictive of risk of stroke
in the long-term. A 70% carotid stenosis was also significantly associated
with stroke at all time points. With logistic regression modeling, incorporat-
ing ABCD2 score and carotid stenosis as independent variables at 90 days,
carotid stenosis remained a significant predictor of stroke. At the end of the
follow-up, stroke occurred in 23 of 247 patients with old infarcts and/or
leukoaraiosis on the CT scan, compared with 6 of 191 with a normal brain
CT scan (odds ratio, 3.16; 95% CI, 1.26-7.94; log-rank P  .01).Comment:Carotid ultrasound imaging, ABCD2 scores, and CT scan-
ning appear important in stratifying risk for stroke after TIA. The practical
p
g
292oint is physicians may use a combination of carotid ultrasound imaging, CT
can, and ABCD2 score to help stratify the urgency of treatment in patients
ith a recent TIA. Patients with high-grade carotid stenosis, CT scans
ndicative of previous infarct, and high ABCD2 scores should be considered
or an urgent admission to the hospital and urgent intervention. Patients
ith negative CT findings, lower ABCD2 scores, and lesser degrees of
arotid stenosis perhaps can be considered for more elective therapy.
eta-Analysis of Usefulness of D-Dimer to Diagnose Acute Aortic
issection
himony A, Filion KB, Mottillo S, et al. Am J Cardiol 2011;107:1227-34.
Conclusion: Plasma D-dimer is a useful screening test to identify
atients who do not have acute aortic dissection.
Summary: Analysis of plasma D-dimer levels may be useful to rule out
cute aortic dissection (AAD; Sodeck G et al, EurHeart J 2007;28:3067-75;
arill KA, J EmergMed 2008;34:367-76). The idea is if D-Dimer levels are
ithin normal reference ranges, AAD is effectively ruled out and further
maging studies are not needed. Previous studies of this issue have had
imited sample sizes and have used different D-dimer cutoff values indicative
f normal (100-900 ng/mL). Some studies have also not had control
roups, precluding calculations of specificity, positive and negative predic-
ive values, and positive and negative likelihood ratios (LRs). The authors’
oal was to perform a systematic review and meta-analysis to examine the
tility of plasma D-Dimer as a screening tool for AAD. They searched
EDLINE and EMBASE for relevant articles to identify studies investigat-
ng plasma D-dimer as screening tool for AAD. A positive D-dimer finding
as considered a value of 500 ng/mL. This level was chosen because it
idely used for ruling out pulmonary emboli. The DerSimonian-Laird
andom effects model was used with pooled data to estimate sensitivities
pecificity, positive and negative predictive values, and positive and negative
Rs. The analysis included seven studies comprising 298 individuals with
AD and 436 without AAD. The pooled data indicated that plasma D-
imer levels for detecting AAD had a sensitivity of 0.97 (95% CI, 0.94-0.99)
nd a negative predictive value of 0.96 (95% CI, 0.9-0.98) in detecting
AD. Specificity (0.56; 95% CI, 0.51-0.60) and positive predictive value
0.60; 95% CI, 0.55-0.66) were low. A negative LR showed an excellent
iscriminative ability (0.06; 95% CI, 0.03-0.12). A positive LR did not have
ood discriminative ability (2.43; 95% CI, 1.89-3.12).
Comment: The high sensitivity and high negative predictive values
ndicate plasma D-dimer level may be a useful screening tool to identify
atients who do not have AAD and therefore may not need additional
maging studies to rule out AAD. Thus, in patients being considered for a
iagnosis of AAD, plasma D-dimer levels can help to identify those unlikely
o benefit from further aortic imaging. However, untreated AAD has a high
ortality rate. Excluding patients from definitive imaging studies because of
negative plasma D-dimer level may be unwise, especially in patients with a
igh-risk profile such as those with Marfan syndrome or uncontrolled
ypertension. D-dimer to rule out AAD is most likely to be useful in
ndividuals with low to moderate risk of actually having AAD. Additional
valuation of D-dimer under specific clinical circumstances is needed before
he test should be advocated as a stand-alone test to exclude AAD.
yocardial Infarction After Carotid Stenting and Endarterectomy:
esults From the Carotid Revascularization Endarterectomy Versus
tenting Trial
lackshear JL, Cutlip DE, Roubin GS, and the CREST investigators.
irculation 2011;123:2571-8.
Conclusion: Patients in the Carotid Revascularization Endarterec-
omy Versus Stenting Trial (CREST) trial randomized to carotid endarter-
ctomy (CEA) had higher rates of myocardial infarction (MI) and cardiac
iomarker positive-only events for myocardial ischemia than those random-
zed to carotid artery stenting (CAS). MI and cardiac biomarker-only
levations were independently associated with increased future mortality.
Summary: Small elevations of cardiac enzymes after a variety of non-
ardiac surgical procedures are associated with increased future mortality
Kim LJ, et al, Circulation 2002;106:2366-71; Landesgerg G, et al, J Am
oll Cardiol 2003;42:1547-54). The authors sought to determine whether
uch a situation exists in patients undergoing carotid artery revasculariza-
ion. They performed a post hoc analysis of the CREST data and explored
he prognostic importance of MI and cardiac biomarker-only elevation in
atients undergoing CEA or CAS. In the CREST protocol, electrocardio-
rams (ECGs) and cardiac biomarker assessments were performed before
